An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck

NCT00684385 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer
Cancer of the Head and Neck

Interventions

DRUG: ZD1839

Sponsor

AstraZeneca